ALPCO / Calprotectin Levels in Human Stool
The ALPCO Calprotectin assay is a widely used diagnostic tool designed to measure calprotectin levels in human stool as a biomarker of intestinal inflammation. Calprotectin, a protein released by activated…
BMS First Episode/Early Phase Schizophrenia
The BMS First Episode/Early Phase Schizophrenia study focuses on individuals experiencing the initial stages of schizophrenia, a critical period that can significantly influence long-term outcomes.This study is anticipated to open…
GSK Irritable Bowel Syndrome — IBS-D & IBS-M
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder that affects millions of adults in the United States. It is characterized by chronic or recurring abdominal pain, bloating, and altered…
Cinphloro — IBS-D
The Cinphloro IBS-D study evaluated novel therapeutic strategies for patients with irritable bowel syndrome with diarrhea (IBS-D), a functional gastrointestinal disorder characterized by chronic abdominal pain, altered bowel habits, and…
CinDome — Diabetic Gastroparesis
The CinDome Diabetic Gastroparesis study evaluated novel therapeutic approaches for managing gastroparesis in patients with diabetes, a condition characterized by delayed gastric emptying.This study has concluded.
Morphic Therapeutics — Crohn’s Disease (Garnet)
Crohn's Disease is a chronic inflammatory bowel disease that causes inflammation anywhere along the digestive tract. Common symptoms include persistent abdominal pain, diarrhea, fatigue, and difficulty maintaining adequate nutrition.This study…
MRM StarFish Ulcerative Colitis
The MRM StarFish Ulcerative Colitis study is designed to evaluate advanced diagnostic and monitoring approaches for patients living with ulcerative colitis, a chronic inflammatory condition of the colon. The study…
VIMA Therapeutics Isolated Dystonia
Dystonia is a neurological movement disorder characterized by involuntary, sustained muscle contractions that cause repetitive movements or abnormal postures. It can affect a single body area, such as the neck,…
EmVenio Research and Health Wizz partner to reach patients across the US
U.S.-based researcher and Health Wizz partner to provide clinical research as a care option DURHAM, N.C., May 14, 2024 /PRNewswire/ -- EmVenio Research and Health Wizz are thrilled to announce their partnership to enhance site management and participant engagement in clinical trials. This collaboration combines EmVenio’s expertise in Localization and Hybrid Clinical Trials with Health Wizz’s innovative platform, which integrates with Electronic Health Records (EHRs) and features a patient engagement app. This partnership aims to streamline the clinical trial process, improving patient enrollment and engagement, and offering healthcare providers a comprehensive, turn-key solution for conducting efficient and patient-centric clinical research.
Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
Partnership to provide clinical research to patients across the country DURHAM, N.C., April XX, 2024 – Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today…